Amprius Technologies enters its June 11 earnings window under a combination of heavy short positioning and the most defensive options setup it has seen all year — an unusually charged backdrop for a stock that has already shed 18% in a week.
The most striking signal this week is in options. Defensive positioning has reached a full-year extreme, with the put/call ratio climbing to 0.716 — the highest reading since data began accumulating twelve months ago, and more than two standard deviations above its 20-day average of 0.58. That sharp shift comes directly on the heels of the May 7 earnings release, which sent the stock down nearly 25% in a single session and 19% over the following five days. Options traders appear to be taking no chances ahead of the next print on June 11.
Short positioning reinforces that caution. At 17.2% of the free float, short interest has built steadily since late April — up from roughly 14% at mid-April, a gain of about 3 percentage points in under a month. That pace of accumulation is the more notable fact here. The absolute level has been stubbornly maintained this week too, barely budging on a day-to-day basis even as the stock fell. However, the borrow market itself is not flashing distress signals. Cost to borrow remains low at 0.42% APR, and availability — while tighter than two weeks ago at 327% of current short interest — is comfortably in normal territory. There is no sign of a forced-cover event in the lending market; shorts have room to hold.
The Street is uniformly bullish in its stated ratings — every active analyst carries a Buy or Overweight — but the most recent formal actions date to early March, when several firms raised targets to the $20-22 range after a strong earnings print. The mean target of $22.13 sits roughly 43% above the current price of $15.48, which in normal circumstances would look attractive. The bear case, however, is straightforward: Amprius is still burning cash, with a net loss of $6.4 million last quarter, and the EV/EBITDA multiple of 182 — down sharply over 30 days as the stock has retreated — reflects a market paying a steep premium for a growth story that has not yet produced positive earnings. The EPS surprise factor score ranks in the 94th percentile, a testament to the company's history of beating estimates, but the 90-day EPS momentum score has dropped to just 1 out of 100 — a signal that forward estimates have stopped improving.
Institutional ownership shows two notable moves. Jane Street added 2.85 million shares (reported April 22), building its stake to just under 5% of shares outstanding. Driehaus Capital Management added 1.4 million shares and Two Sigma added 2.1 million, both as of the March 31 filing. Those are material accumulation moves by quantitative and active managers at levels above the current price — providing some context for the support base. On the other side, director Kang Sun sold just over 1.5 million shares in early April at prices around $15.73-$16.78, pulling roughly $23.9 million out of the stock. A second director, Wen Hsuan Hsieh, sold more than 400,000 shares in mid-March at around $18-19. The net 90-day insider figure across all transactions is a positive 4.6 million shares, but that is almost entirely a function of the offsetting institutional accumulation structure; the named directors were net sellers.
The May 7 earnings history is worth noting without extrapolating from it. The stock dropped 24.7% the day after that report and a further 19% over the subsequent week — the most severe post-earnings reaction in the recent record. The June 11 event is the next scheduled catalyst, and with a PCR z-score at 2.04 and short interest holding near its 30-day high, the market has already priced in considerable anxiety. What to watch between now and then: whether the SI % of float pushes above 18% (the point at which the May accumulation wave started), and whether borrow costs start to move — currently flat near 0.42%, any sustained upward drift would suggest new demand for shorts is pressing against available supply.
See the live data behind this article on ORTEX.
Open AMPX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
